<?xml version="1.0" encoding="UTF-8"?>
<ref id="B53-vaccines-07-00074">
 <label>53.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Beretta</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Moreau</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Bouvin-Pley</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Essat</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Goujard</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Chaix</surname>
    <given-names>M.-L.</given-names>
   </name>
   <name>
    <surname>Hu√©</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Meyer</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Barin</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Braibant</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Phenotypic properties of envelope glycoproteins of transmitted HIV-1 variants from patients belonging to transmission chains</article-title>
  <source>AIDS</source>
  <year>2018</year>
  <volume>32</volume>
  <fpage>1917</fpage>
  <lpage>1926</lpage>
  <pub-id pub-id-type="doi">10.1097/QAD.0000000000001906</pub-id>
  <pub-id pub-id-type="pmid">29927786</pub-id>
 </element-citation>
</ref>
